We think the long-lasting ROS production in IL-4-treated microglia (elevated for at least 2 days) is likely mediated by mitochondria, because PKG is known to stimulate mitochondrial ROS production in cardiomyocytes and a neuroblastoma cell line (28–30). The gene discussed is PRKG1; the disease is neuroblastoma.